1. Home
  2. PPTA vs STOK Comparison

PPTA vs STOK Comparison

Compare PPTA & STOK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Perpetua Resources Corp.

PPTA

Perpetua Resources Corp.

N/A

Current Price

$15.42

Market Cap

2.1B

ML Signal

N/A

Logo Stoke Therapeutics Inc.

STOK

Stoke Therapeutics Inc.

N/A

Current Price

$26.81

Market Cap

2.0B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
PPTA
STOK
Founded
2011
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Precious Metals
Biotechnology: Pharmaceutical Preparations
Sector
Basic Materials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.1B
2.0B
IPO Year
2011
2019

Fundamental Metrics

Financial Performance
Metric
PPTA
STOK
Price
$15.42
$26.81
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
7
14
Target Price
$36.90
★ $46.38
AVG Volume (30 Days)
★ 1.7M
938.4K
Earning Date
11-13-2026
10-29-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 92.73
EPS
★ N/A
N/A
Revenue
N/A
★ $184,420,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$35.58
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
★ 404.50
52 Week Low
$15.31
$22.05
52 Week High
$37.37
$40.22

Technical Indicators

Market Signals
Indicator
PPTA
STOK
Relative Strength Index (RSI) 35.94 50.80
Support Level N/A $25.65
Resistance Level $19.12 $33.39
Average True Range (ATR) 1.39 1.33
MACD -0.16 0.00
Stochastic Oscillator 7.34 35.55

Price Performance

Historical Comparison
PPTA
STOK

About PPTA Perpetua Resources Corp.

Perpetua Resources Corp is engaged in acquiring mining properties with the intention of exploring, evaluating, developing and placing them into production, if warranted. Its principal mineral project is the Stibnite Gold Project in Idaho, USA, which contains several gold, silver and antimony mineral deposits. The company's current focus is to redevelop three of the Deposits known as the Hangar Flats Deposit, West End Deposit and Yellow Pine Deposit, all of which are located within the Stibnite Gold Project, as well as reprocess certain historical tailings located on the Project. It operates in one segment: mineral exploration and development in the United States.

About STOK Stoke Therapeutics Inc.

Stoke Therapeutics Inc is a biotechnology company dedicated to restoring protein expression by harnessing the body's potential with RNA medicine. Its proprietary TANGO (Targeted Augmentation of Nuclear Gene Output) approach, Stoke is developing antisense oligonucleotides (ASOs) to restore naturally-occurring protein levels selectively. Its first medicine in development, zorevunersen, has demonstrated the potential for disease modification in patients with Dravet syndrome. The company provides early programs focused on multiple targets, including haploinsufficiency diseases of the central nervous system and eye, to up-regulate the protein expression of the underlying disease gene in a mutation-agnostic manner.

Share on Social Networks: